PROFESSIONAL EDITION

The largest community of pharma leaders

Turnstone Biologics Acquires Novel Cell Therapy Platform

NEW YORK–(BUSINESS WIRE)–Acquisition of Myst Therapeutics adds proprietary tumor infiltrating lymphocyte (“TIL”) technology and programs to Turnstone’s growing portfolio
Source Read More

Recent Articles